Singh N, Al-Naamani N, Brown M, Long G, Thenappan T, Umar S
Expert Rev Respir Med. 2024; 18(3-4):189-205.
PMID: 38801029
PMC: 11713041.
DOI: 10.1080/17476348.2024.2361037.
Tuder R, Gandjeva A, Williams S, Kumar S, Kheyfets V, Hatton-Jones K
Am J Respir Crit Care Med. 2024; 210(3):329-342.
PMID: 38568479
PMC: 11348978.
DOI: 10.1164/rccm.202307-1310OC.
Ranasinghe A, Tennakoon T, Schwarz M
Cells. 2024; 13(3.
PMID: 38334636
PMC: 10854593.
DOI: 10.3390/cells13030244.
Mocumbi A, Humbert M, Saxena A, Jing Z, Sliwa K, Thienemann F
Nat Rev Dis Primers. 2024; 10(1):1.
PMID: 38177157
DOI: 10.1038/s41572-023-00486-7.
Harrington J, Ryter S, Plataki M, Price D, Choi A
Physiol Rev. 2023; 103(4):2349-2422.
PMID: 37021870
PMC: 10393386.
DOI: 10.1152/physrev.00058.2021.
Vascular stiffening in aging females with a hypertension-induced HIF2A gain-of-function mutation.
Volkova E, Procell L, Kong L, Santhanam L, Gerecht S
Bioeng Transl Med. 2023; 8(2):e10403.
PMID: 36925716
PMC: 10013765.
DOI: 10.1002/btm2.10403.
Tensions in Taxonomies: Current Understanding and Future Directions in the Pathobiologic Basis and Treatment of Group 1 and Group 3 Pulmonary Hypertension.
Gu S, Goel K, Forbes L, Kheyfets V, Yu Y, Tuder R
Compr Physiol. 2023; 13(1):4295-4319.
PMID: 36715285
PMC: 10392122.
DOI: 10.1002/cphy.c220010.
Analysis of mG methylation modification patterns and pulmonary vascular immune microenvironment in pulmonary arterial hypertension.
Wang D, Mo Y, Zhang D, Bai Y
Front Immunol. 2022; 13:1014509.
PMID: 36544768
PMC: 9762157.
DOI: 10.3389/fimmu.2022.1014509.
The Role of HSP90 Inhibitors in the Treatment of Cardiovascular Diseases.
Qi S, Yi G, Yu K, Feng C, Deng S
Cells. 2022; 11(21).
PMID: 36359837
PMC: 9657168.
DOI: 10.3390/cells11213444.
Exercise metabolomics in pulmonary arterial hypertension: Where pulmonary vascular metabolism meets exercise physiology.
Lee M, Menezes T, Reisz J, Ferreira E, Graham B, Oliveira R
Front Physiol. 2022; 13:963881.
PMID: 36171971
PMC: 9510894.
DOI: 10.3389/fphys.2022.963881.
Hypoxia: molecular pathophysiological mechanisms in human diseases.
Della Rocca Y, Fonticoli L, Rajan T, Trubiani O, Caputi S, Diomede F
J Physiol Biochem. 2022; 78(4):739-752.
PMID: 35870078
PMC: 9684243.
DOI: 10.1007/s13105-022-00912-6.
Contribution of fatty acid oxidation to the pathogenesis of pulmonary hypertension.
Lee M, Sanders L, Kumar R, Hernandez-Saavedra D, Yun X, Ford J
Am J Physiol Lung Cell Mol Physiol. 2022; 323(3):L355-L371.
PMID: 35763400
PMC: 9448289.
DOI: 10.1152/ajplung.00039.2022.
Arctigenin prevents monocrotaline-induced pulmonary arterial hypertension in rats.
Jiang W, Han X, Zhang Y, Xia Q, Zhang J, Wang F
RSC Adv. 2022; 9(1):552-559.
PMID: 35521617
PMC: 9059326.
DOI: 10.1039/c8ra07892k.
Peripheral Arterial Stiffness in Acute Pulmonary Embolism and Pulmonary Hypertension at Short-Term Follow-Up.
Papa S, Miotti C, Manzi G, Scoccia G, Luongo F, Toto F
J Clin Med. 2021; 10(14).
PMID: 34300176
PMC: 8307119.
DOI: 10.3390/jcm10143008.
PDGF mediates pulmonary arterial smooth muscle cell proliferation and migration by regulating NFATc2.
Zhao F, Xu S, Zhang C, Liu J, Zhang Y, Yang J
Mol Med Rep. 2020; 23(1).
PMID: 33179105
PMC: 7684858.
DOI: 10.3892/mmr.2020.11677.
Cancer and pulmonary hypertension: Learning lessons and real-life interplay.
Pullamsetti S, Nayakanti S, Chelladurai P, Mamazhakypov A, Mansouri S, Savai R
Glob Cardiol Sci Pract. 2020; 2020(1):e202010.
PMID: 33150154
PMC: 7590929.
DOI: 10.21542/gcsp.2020.10.
DNA Damage and Repair in Pulmonary Arterial Hypertension.
Sharma S, Aldred M
Genes (Basel). 2020; 11(10).
PMID: 33086628
PMC: 7603366.
DOI: 10.3390/genes11101224.
The Role and Regulation of Pulmonary Artery Smooth Muscle Cells in Pulmonary Hypertension.
He S, Zhu T, Fang Z
Int J Hypertens. 2020; 2020:1478291.
PMID: 32850144
PMC: 7441461.
DOI: 10.1155/2020/1478291.
Perspective: pathobiological paradigms in pulmonary hypertension, time for reappraisal.
Tuder R, Stenmark K
Am J Physiol Lung Cell Mol Physiol. 2020; 318(6):L1131-L1137.
PMID: 32186206
PMC: 7347272.
DOI: 10.1152/ajplung.00067.2020.
Hot topics in the mechanisms of pulmonary arterial hypertension disease: cancer-like pathobiology, the role of the adventitia, systemic involvement, and right ventricular failure.
Spiekerkoetter E, Goncharova E, Guignabert C, Stenmark K, Kwapiszewska G, Rabinovitch M
Pulm Circ. 2019; 9(4):2045894019889775.
PMID: 31798835
PMC: 6868582.
DOI: 10.1177/2045894019889775.